D-(R)- and L-(S)-3-alkylaminopyrrolidino-substituted dihydrodibenzo (b,f)- and-(b,e)thiepins, xanthenes, and diphenylmethanes.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D001555:Benzene Derivatives / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D003988:Dibenzothiepins / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009904:Optical Rotation; D010095:Oxotremorine / Q000633:toxicity; D010276:Parasympatholytics / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology / Q000633:toxicity; D051381:Rats; D012702:Serotonin Antagonists; D012890:Sleep / Q000187:drug effects; D013329:Structure-Activity Relationship; D014966:Xanthenes / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity
D000978:Antiparkinson Agents; D001463:Barbiturates; D001555:Benzene Derivatives; D003988:Dibenzothiepins; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D011759:Pyrrolidines; D012702:Serotonin Antagonists; D014966:Xanthenes; D010095:Oxotremorine